Salicylic Acid (2 Hydroxybenzoic Acid)

Subscribe to Selected New Research on Salicylic Acid

779 relevant articles (41 outcomes, 60 trials/studies) found for this Bio-Agent

Description: A compound obtained from the bark of the white willow and wintergreen leaves, and also prepared synthetically. It has bacteriostatic, fungicidal, and keratolytic actions. Its salts, the salicylates, are used as analgesics. (From Dorland's, 28th ed)

Also Known As:

2 Hydroxybenzoic Acid; 2-Hydroxybenzoic Acid; o-Hydroxybenzoic Acid; ortho-Hydroxybenzoic Acid; Acid, 2-Hydroxybenzoic; Acid, Salicylic; Acid, o-Hydroxybenzoic; Acid, ortho-Hydroxybenzoic; o Hydroxybenzoic Acid; ortho Hydroxybenzoic Acid

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Phenols: 197

Hydroxybenzoic Acids: 1

Hydroxybenzoic Acids: 1

Hydroxybenzoic Acids: 1

Salicylic Acids: 6

Salicylic Acid: 779

Salicylates: 559

Experts

1.	Ueda, Setsuko: 2 articles (07/2008 - 02/2008)
2.	Lu, Guoquan: 2 articles (05/2008 - 06/2007)
3.	Mahmoud, Sabry Younis: 2 articles (05/2008 - 06/2007)
4.	Fayez, Khalaf Ali: 2 articles (05/2008 - 06/2007)
5.	Radwan, Deya Eldeen Mohammed: 2 articles (05/2008 - 06/2007)
6.	Bari, Arfan Ul: 2 articles (04/2007 - 03/2005)
7.	Iqbal, Zafar: 2 articles (04/2007 - 03/2005)
8.	Rahman, Simeen Ber: 2 articles (04/2007 - 03/2005)
9.	Danielson, John R: 2 articles (01/2005 - 10/2004)
10.	Walter, Robert J: 2 articles (01/2005 - 10/2004)

Related Diseases

1.	Warts (Wart) 01/01/1989 - "A clinical study was conducted to evaluate the efficacy of a new delivery system for administering salicylic acid for the treatment of verruca vulgaris" 01/01/1988 - "The results of this study suggest that high-potency salicylic acid promotes prompt resolution of warts, which may enhance patient compliance." 03/01/2004 - "Efficacy and benefit of a 5-FU/salicylic acid preparation in the therapy of common and plantar warts--systematic literature review and meta-analysis]" 01/01/1998 - "These spectral changes are believed to be more consistent with salicylic acid bonding within the human papillomavirus-containing verruca tissue rather than simple acid dissociation upon dissolution in water within the tissue" 01/01/1998 - "In the centre of the verruca, the molecular structure of the skin was altered showing evidence of the interaction with salicylic acid" Order ALL the reference details at left...
2.	Psoriasis (Pustulosis Palmaris et Plantaris) 01/01/2004 - "Light and Heat Energy (LHE) selective photothermolysis combined with salicylic acid appears to be a practical modality for the treatment of mild to moderate psoriasis" 01/01/1999 - "The role of salicylic acid in the treatment of psoriasis." 01/01/1991 - "Salicylic acid has been widely used in the topical treatment of psoriasis" 01/01/1991 - "Topical salicylic acid interferes with UVB therapy for psoriasis." 01/01/1990 - "In all patients the serum concentration of salicylic acid increased systematically and the concentration depended on the amount of ointment used and on psoriasis form" Order ALL the reference details at left...
3.	Ulcerative Colitis 07/02/1983 - "Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth." 11/01/2004 - "In the present work, we aimed to analyse the effects and underlying molecular mechanisms of 5-amino salicylic acid (5-ASA) and derivatives on apoptosis of LPL and peripheral blood lymphocytes (PBL) in patients with CD compared with ulcerative colitis (UC) and in non-inflammatory controls" 12/01/1998 - "5-[4-(2-Carboxyethylcarbamoyl)phenylazo]salicylic acid disodium salt dihydrate (CAS 80573-04-2, BX661A) is developed as a therapeutic agent for ulcerative colitis" 11/01/1998 - "5-[4-(2-Carboxyethylcarbamoyl)phenylazo]salicylic acid disodium salt dihydrate (CAS 80573-04-2, BX661A) is being developed as a therapeutic drug for ulcerative colitis" 10/01/1998 - "5-[4-(2-Carboxyethylcarbamoyl)phenylazo]salicylic acid disodium salt dihydrate (CAS 80573-04-2, BX661A) is developed as a therapeutic agent for ulcerative colitis" Order ALL the reference details at left...
4.	Acne Vulgaris 03/01/2006 - "CONCLUSION: Salicylic acid peels are beneficial in whitening the face of Asian patients with acne" 12/01/2003 - "CONCLUSION: Salicylic acid peels are an effective and safe therapy for acne vulgaris in Asian patients." 03/01/1992 - "In three placebo-controlled studies and a comedolytic assay, salicylic acid pads reduced the number of primary lesions and thereby the number and severity of all lesions associated with acne" 03/01/1992 - "A review of four clinical studies and a comedolytic assay attests to the efficacy and safety of 0.5% and 2% solutions of salicylic acid for the treatment of acne vulgaris" 03/01/2006 - "OBJECTIVE: To assess the whitening effect of salicylic acid peels in Asian patients with acne objectively by the colorimetric method" Order ALL the reference details at left...
5.	Infection 06/01/1977 - "Best results in fungus infection of the ear was obtained by daily packing of the external meatus by a wick of gauze soaked in 2% salicylic acid in alcohol (70%) for a few days after removal of the fungal mass." 05/01/2008 - "In this study, morphological, ultrastructural and physiological modifications of faba bean (Vicia faba cv Giza 461) leaves in response to bean yellow mosaic virus (BYMV) infection and salicylic acid (SA) treatments were examined" 01/01/2009 - "The expression analysis by semi-quantitative RT-PCR showed that GhRdRP was induced by salicylic acid (SA), 5-chloroSA (5-CSA) and fungal infection of Rhizoctonia solani Kuhn" 11/01/2008 - "Overexpression of OsDRF1 in transgenic tobacco resulted in enhanced disease resistance against tomato mosaic virus (ToMV) and Pseudomonas syringae pv. tabaci and strengthened expression of defense-related genes after salicylic acid treatment or ToMV infection" 05/01/2008 - "Significantly elevated levels of salicylic acid and expression of a defense-related gene (HSR203J) were observed in S-4-4 leaves following blue mold infection" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Aspirin (Acetylsalicylic Acid)
2.	Betamethasone (Celestone)
3.	Lactic Acid
4.	calcipotriene (calcipotriol)
5.	Fluorouracil (Carac)
6.	Tacrolimus (Prograf)
7.	mometasone furoate (mometasone)
8.	ethylene
9.	Adrenal Cortex Hormones (Corticosteroids)
10.	Acetaminophen (Paracetamol)

Related Therapies and Procedures

1.	Cryotherapy (Therapy, Cold)
2.	Dye Lasers
3.	Remission Induction
4.	Aftercare (After-Treatment)
5.	Enema (Enemas)

Best Treatments:
Research Summary Report
on Warts

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 226 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>